A patient with fibromyalgia at a general practitioner's appointment – what to look out for
https://doi.org/10.33667/2078-5631-2025-28-7-14
Abstract
Fibromyalgia (FM) is one of the most prevalent chronic diseases in the developed world, with a prevalence of 2–3 cases per 100 inhabitants. The predominant manifestation of FM is characterised by persistent generalized pain, frequently accompanied by a plethora of psychoemotional and dysfunctional disorders, including sleep disturbances, fatigue, anxiety and depression, headaches, irritable bowel syndrome, and numerous others. FM frequently occurs in conjunction with systemic rheumatic diseases. For instance, in rheumatoid arthritis and spondyloarthritis, the frequency reaches 20–30%.
Despite widespread interest, FM remains a largely understudied pathology to date. The diversity of clinical symptoms, excessive emotionality and difficult psychological mood of patients often determine difficulties in the diagnosis and treatment of this disease. This determines the need to form a clear algorithm of actions, which will help the general practitioner to successfully consult patients with suspicion of this disease, to conduct an effective diagnostic search and determine the possibilities of its complex therapy.
About the Authors
A. E. Karateev
V.A. Nasonova Research Institute of Rheumatology
Russian Federation
Russian Federation
Karateev Andrey E., DM Sci (habil.), head of the Laboratory of Pain
Pathophysiology and Polymorphism of Rheumatic Diseases
SCOPUD ID: 6603615916
Moscow
E. S. Filatova
V.A. Nasonova Research Institute of Rheumatology
Russian Federation
Russian Federation
Filatova Ekaterina S., DM Sci (habil.), senior researcher at the Laboratory of Pathophysiology of Pain and Polymorphism of Rheumatic Diseases
SCOPUS ID: 57212194160
Moscow
A. M. Lila
V.A. Nasonova Research Institute of Rheumatology; Russian Medical Academy of Continuing Professional Education
Russian Federation
Russian Federation
Lila Alexander M., RAS corresponding member, DM Sci (habil.), professor, director; head of Dept of Rheumatology, chief freelance rheumatologist of the Ministry of Health of the Russian Federation, Honored Doctor of the Russian Federation
SCOPUS ID: 6602550827
Moscow
References
1. Davydov O. S., Glebov M.V. Fibromyalgia. Russian Journal of Pain. 2020; 18 (3): 66–74. (In Russ.). https://doi.org/10.17116/pain20201803166
2. Ablin JN. Fibromyalgia: are you a genetic/environmental disease? Pain Rep. 2025 Apr 18; 10 (3): e1256. DOI: 10.1097/PR9.0000000000001256
3. Cabo-Meseguer A, Cerdá-Olmedo G, Trillo-Mata JL. Fibromyalgia: Prevalence, epidemiologic profiles and economic costs. Med Clin (Barc). 2017 Nov 22; 149 (10): 441–448. English, Spanish. DOI: 10.1016/j.medcli.2017.06.008
4. Coles ML, Weissmann R, Uziel Y. Juvenile primary Fibromyalgia Syndrome: epidemiology, etiology, pathogenesis, clinical manifestations and diagnosis. Pediatr Rheumatol Online J. 2021 Mar 1; 19 (1): 22. DOI: 10.1186/s12969-021-00493-6
5. Khoja O, Mulvey M, Astill S, Tan AL, Sivan M. New-Onset Chronic Musculoskeletal Pain Following COVID 19 Infection Fulfils the Fibromyalgia Clinical Syndrome Criteria: A Preliminary Study. Biomedicines. 2024 Aug 23; 12 (9): 1940. DOI: 10.3390/biomedicines12091940
6. Stefanou MI, Panagiotopoulos E, Palaiodimou L, Bakola E, Smyrnis N, Papadopoulou M, Moschovos C, Paraskevas GP, Rizos E, Boutati E, Tzavellas E, Gatzonis S, Mengel A, Giannopoulos S, Tsiodras S, Kimiskidis VK, Tsivgoulis G. Current update on the neurological manifestations of long COVID: more questions than answers. EXCLI J. 2024 Nov 27; 23: 1463–1486. DOI: 10.17179/excli2024-7885
7. Parsirad M, Oomen-Lochtefeld S, Suerig B, Wang C. Has the COVID19 Pandemic Impacted the Management of Chronic Musculoskeletal Pain? Curr Rheumatol Rep. 2023 Jul; 25 (7): 128–143. DOI: 10.1007/s11926-023-01103-y
8. Di Matteo A, Bathon JM, Emery P. Rheumatoid arthritis. Lancet. 2023 Nov 25; 402 (10416): 2019–2033. DOI: 10.1016/S0140-6736(23)01525-8
9. Navarro-Compán V, Sepriano A, El-Zorkany B, van der Heijde D. Axial spondyloarthritis. Ann Rheum Dis. 2021 Dec; 80 (12): 1511–1521. DOI: 10.1136/annrheumdis-2021-221035
10. Dalbeth N, Gosling AL, Gaffo A, Abhishek A. Gout. Lancet. 2021 May 15; 397 (10287): 1843–1855. DOI: 10.1016/S0140-6736(21)00569-9
11. Wolfe F, Michaud K, Klooster PMT, Rasker JJ. Looking at fibromyalgia differently – An observational study of the meaning and consequences of fibromyalgia as a dimensional disorder. Semin Arthritis Rheum. 2023 Feb; 58: 152145. DOI: 10.1016/j.semarthrit.2022.152145
12. Clauw D, Sarzi-Puttini P, Pellegrino G, Shoenfeld Y. Is fibromyalgia an autoimmune disorder? Autoimmun Rev. 2024 Jan; 23 (1): 103424. DOI: 10.1016/j.autrev.2023.103424
13. Adawi M, Chen W, Bragazzi NL, Watad A, McGonagle D, Yavne Y, Kidron A, Hodadov H, Amital D, Amital H. Suicidal Behavior in Fibromyalgia Patients: Rates and Determinants of Suicide Ideation, Risk, Suicide, and Suicidal Attempts-A Systematic Review of the Literature and Meta-Analysis of Over 390,000 Fibromyalgia Patients. Front Psychiatry. 2021 Nov 19; 12: 629417. DOI: 10.3389/fpsyt.2021.629417
14. 2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria / F. Wolfe, D.J. Clauw, M.A. Fitzcharles [et al.]. Seminars in arthritis and rheumatism. 2016; 46 (3): 319–329.
15. Colombo B, Zanella E, Galazzi A, Arcadi P. The Experience of Stigma in People Affected by Fibromyalgia: A Metasynthesis. J Adv Nurs. 2025 Jan 21. DOI: 10.1111/jan.16773
16. Häuser W, Sarzi-Puttini P, Fitzcharles MA. Fibromyalgia syndrome: under-, over- and misdiagnosis. Clin Exp Rheumatol. 2019 Jan-Feb; 37 Suppl 116 (1): 90–97.
17. Aloush V, Niv D, Ablin JN, Yaish I, Elkayam O, Elkana O. Good pain, bad pain: illness perception and physician attitudes towards rheumatoid arthritis and fibromyalgia patients. Clin Exp Rheumatol. 2021 May-Jun; 39 Suppl 130 (3): 54–60. DOI: 10.55563/clinexprheumatol/u1nbxz
18. Homma M, Ishikawa H, Kiuchi T. Illness perceptions and negative responses from medical professionals in patients with fibromyalgia: Association with patient satisfaction and number of hospital visits. Patient Educ Couns. 2018 Mar; 101 (3): 532–540. DOI: 10.1016/j.pec.2017.08.014
19. Clark P, Paiva ES, Ginovker A, Salomón PA. A patient and physician survey of fibromyalgia across Latin America and Europe. BMC Musculoskelet Disord. 2013 Jun 14; 14: 188. DOI: 10.1186/1471 2474 14 188. PMID: 23767857; PMCID: PMC3689629.
20. Salaffi F, Farah S, Bianchi B, Lommano MG, Di Carlo M. Delay in fibromyalgia diagnosis and its impact on the severity and outcome: a large cohort study. Clin Exp Rheumatol. 2024 Jun; 42 (6): 1198–1204. DOI: 10.55563/clinexprheumatol/ta9xtc
21. Wigers SH, Veierød MB, Mengshoel AM, Forseth KØ, Dahli MP, Juel NG, Natvig B. Healthcare experiences of fibromyalgia patients and their associations with satisfaction and pain relief. A patient survey. Scand J Pain. 2024 Apr 16; 24 (1). DOI: 10.1515/sjpain-2023-0141. PMID: 38625666.
22. Rico-Villademoros F, Postigo-Martin P, Garcia-Leiva JM, Ordoñez-Carrasco JL, Calandre EP. Patterns of pharmacologic and non-pharmacologic treatment, treatment satisfaction and perceived tolerability in patients with fibromyalgia: a patients' survey. Clin Exp Rheumatol. 2020 Jan-Feb; 38 Suppl 123 (1): 72–78.
23. Rodionova Yu.V. In search of a modern character of a doctor: what examples to learn from the greats? Part I. Cardiovascular Therapy and Prevention. 2023; 22 (2S): 3600. (InRuss.). https://doi.org/10.15829/1728-8800-2023-3600. EDN: XQNFGJ
24. Capek M. Thinking differently in rheumatological psychosomatic conditions (changing the doctor's style of thinking). Sovremennaya Revmatologiya=Modern Rheumatology Journal. 2021; 15 (2): 7–16. (In Russ.). DOI: 10.14412/1996-7012-2021-2-7-16
25. Clauw DJ. From fibrositis to fibromyalgia to nociplastic pain: how rheumatology helped get us here and where do we go from here? Ann Rheum Dis. 2024 Oct 21; 83 (11): 1421–1427. DOI: 10.1136/ard-2023-225327
26. Winslow BT, Vandal C, Dang L. Fibromyalgia: Diagnosis and Management. Am Fam Physician. 2023 Feb; 107 (2): 137–144.
27. Siracusa R, Paola RD, Cuzzocrea S, Impellizzeri D. Fibromyalgia: Pathogenesis, Mechanisms, Diagnosis and Treatment Options Update. Int J Mol Sci. 2021 Apr 9; 22 (8): 3891. DOI: 10.3390/ijms22083891
28. Costa LP, Ferreira MA. The (in)visibility of fibromyalgia through its symptoms and the challenges of its diagnosis and therapy. Rev Bras Enferm. 2024 Jun 14; 77 (2): e20230363. DOI: 10.1590/0034-7167-2023-0363
29. Fitzmaurice BC, Grenfell RL, Heneghan NR, Rayen ATA, Soundy AA. The Fibromyalgia Decomposition Phenomenon: A Reflexive Thematic Analysis. Behav Sci (Basel). 2024 Jan 11; 14 (1): 47. DOI: 10.3390/bs14010047
30. Byrne A, Jones K, Backhouse M, Rose F, Moatt E, van der Feltz-Cornelis C. Patient and primary care practitioners' perspectives on consultations for fibromyalgia: a qualitative evidence synthesis. Prim Health Care Res Dev. 2023 Sep 26; 24: e58. DOI: 10.1017/S1463423623000506
31. Culvenor AG, Øiestad BE, Hart HF, Stefanik JJ, Guermazi A, Crossley KM. Prevalence of knee osteoarthritis features on magnetic resonance imaging in asymptomatic uninjured adults: a systematic review and meta-analysis. Br J Sports Med. 2019 Oct; 53 (20): 1268–1278. DOI: 10.1136/bjsports 2018-099257
32. Al Sharie S, Varga SJ, Al-Husinat L, Sarzi-Puttini P, Araydah M, Bal'awi BR, Varrassi G. Unraveling the Complex Web of Fibromyalgia: A Narrative Review. Medicina (Kaunas). 2024 Feb 4; 60 (2): 272. DOI: 10.3390/medicina60020272
33. Annemans L, Le Lay K, Taïeb C. Societal and patient burden of fibromyalgia syndrome. Pharmacoeconomics. 2009; 27 (7): 547–59. DOI: 10.2165/11313650-000000000-00000
34. Eccles JA, Thompson B, Themelis K, Amato ML, Stocks R, Pound A, Jones AM, Cipinova Z, Shah-Goodwin L, Timeyin J, Thompson CR, Batty T, Harrison NA, Critchley HD, Davies KA. Beyond bones: The relevance of variants of connective tissue (hypermobility) to fibromyalgia, ME/CFS and controversies surrounding diagnostic classification: an observational study. Clin Med (Lond). 2021 Jan; 21 (1): 53–58. DOI: 10.7861/clinmed.2020-0743
35. Hudson N, Starr MR, Esdaile JM, Fitzcharles MA. Diagnostic associations with hypermobility in rheumatology patients. Br J Rheumatol. 1995 Dec; 34 (12): 1157–61. DOI: 10.1093/rheumatology/34.12.1157
36. Staud R. Evidence for shared pain mechanisms in osteoarthritis, low back pain, and fibromyalgia. Curr Rheumatol Rep. 2011 Dec; 13 (6): 513–20. DOI: 10.1007/s11926-011-0206-6
37. Mahgoub MY, Elnady BM, Abdelkader HS, Abdelhalem RA, Hassan WA. Comorbidity of Fibromyalgia in Primary Knee Osteoarthritis: Potential Impact on Functional Status and Quality of Life. Open Access Rheumatol. 2020 May 5; 12: 55–63. DOI: 10.2147/OARRR.S252748
38. De Maya Tobarra M, Zúnica-García S, Gracia-Sánchez A, Chicharro-Luna E. Relationship Between Morphofunctional Alterations of the Foot and Its Functionality in Patients with Fibromyalgia Syndrome: A Case-Control Study. J Clin Med. 2024 Oct 27;13 (21): 6439. DOI: 10.3390/jcm13216439 39. https://www.rlsnet.ru/active-substance/duloksetin 2691#primenenie
39. https://www.rlsnet.ru/drugs/pregabalin-42761#pokazaniia-k-primeneniiu
Review
For citations:
Karateev A.E., Filatova E.S., Lila A.M. A patient with fibromyalgia at a general practitioner's appointment – what to look out for. Medical alphabet. 2025;(28):7-14. (In Russ.) https://doi.org/10.33667/2078-5631-2025-28-7-14
Views:
219
JATS XML
Email this article 